A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...

SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to ...

A new test detecting fetal DNA in a mother?s blood could reduce invasive procedures, such as amniocentesis and removal of tissue from the uterus, to predict birth defects. In “A Non-invasive Test for ...

Please provide your email address to receive an email when new articles are posted on . Cell-free fetal antigen analyses had 100% consistency for 465 calls on antigens in which women were ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Advances in modern medicine allow us to treat fetuses and newborn babies for genetic or inherited diseases. Advances in modern medicine allow us to treat fetuses and newborn babies for genetic or ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

In the past, parents-to-be concerned with the genetic state of their gestating offspring had to test both the mother’s and father’s blood in order to determine what traits the child would likely ...

SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwide SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, ...

Myriad Genetics (MYGN) continues to empower parents with increased access to prenatal testing. SneakPeek is now available over the counter in more than 8,800 retail locations nationwide. The product ...